CH650675A5 - Composition pharmaceutique notamment a action anti-ischemique. - Google Patents

Composition pharmaceutique notamment a action anti-ischemique. Download PDF

Info

Publication number
CH650675A5
CH650675A5 CH6259/81A CH625981A CH650675A5 CH 650675 A5 CH650675 A5 CH 650675A5 CH 6259/81 A CH6259/81 A CH 6259/81A CH 625981 A CH625981 A CH 625981A CH 650675 A5 CH650675 A5 CH 650675A5
Authority
CH
Switzerland
Prior art keywords
trimethoxybenzylpiperazine
patients
treatment
activity
results
Prior art date
Application number
CH6259/81A
Other languages
English (en)
French (fr)
Inventor
Jean-Claude Arnaud
Michelle Devissaguet
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9246419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH650675(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of CH650675A5 publication Critical patent/CH650675A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH6259/81A 1980-09-30 1981-09-29 Composition pharmaceutique notamment a action anti-ischemique. CH650675A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8020919A FR2490963B1 (fr) 1980-09-30 1980-09-30 Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine

Publications (1)

Publication Number Publication Date
CH650675A5 true CH650675A5 (fr) 1985-08-15

Family

ID=9246419

Family Applications (1)

Application Number Title Priority Date Filing Date
CH6259/81A CH650675A5 (fr) 1980-09-30 1981-09-29 Composition pharmaceutique notamment a action anti-ischemique.

Country Status (14)

Country Link
US (1) US4407801A (cg-RX-API-DMAC7.html)
AU (1) AU550761B2 (cg-RX-API-DMAC7.html)
BE (1) BE890568A (cg-RX-API-DMAC7.html)
CA (1) CA1169775A (cg-RX-API-DMAC7.html)
CH (1) CH650675A5 (cg-RX-API-DMAC7.html)
DE (1) DE3139005A1 (cg-RX-API-DMAC7.html)
FR (1) FR2490963B1 (cg-RX-API-DMAC7.html)
GB (1) GB2084019B (cg-RX-API-DMAC7.html)
GR (1) GR75803B (cg-RX-API-DMAC7.html)
IE (1) IE51764B1 (cg-RX-API-DMAC7.html)
IT (1) IT1171557B (cg-RX-API-DMAC7.html)
LU (1) LU83654A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ198435A (cg-RX-API-DMAC7.html)
ZA (1) ZA816766B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448776A (en) * 1981-02-12 1984-05-15 Karl Bucher Method of using certain substituted aliphatic secondary amines or their salts for easing breathing
SE8403912D0 (sv) * 1984-07-30 1984-07-30 Pharmacia Ab Lekemedelssats eller -komposition
FR2717687B1 (fr) * 1994-03-24 1996-06-14 Adir Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale.
EP1104673A1 (en) * 1999-11-30 2001-06-06 Bayer Classics A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
FR2805463B1 (fr) * 2000-02-25 2003-01-24 Adir UTILISATION DE LA TRIMETAZIDINE POUR L'OBTENTION DE COMPOSITIONS PHARMACEUTIQUES DESTINEES A INHIBER L'ACYL-CoA ACETYLTRANSFERASE
FR2818549B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Composition pharmaceutique solide thermoformable pour la liberation controlee de trimetazidine
WO2007116243A2 (en) * 2006-04-10 2007-10-18 Mintails Limited Method for treating fibromyalgia and related conditions
EA009776B1 (ru) * 2006-07-18 2008-04-28 Мераб Ревазович Кокеладзе Способ изготовления таблетированной лекарственной формы триметазидина дигидрохлорида и ее состав
FR2986431B1 (fr) * 2012-02-03 2017-03-17 Servier Lab Composition pharmaceutique a liberation prolongee de trimetazidine, son procede de fabrication et son utilisation dans des traitements therapeutiques
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
CN105055352A (zh) * 2015-08-11 2015-11-18 瑞阳制药有限公司 盐酸曲美他嗪片及其制备方法
US11123345B2 (en) * 2016-11-21 2021-09-21 Saghmos Therapeutics, Inc. Prevention and/or treatment of contrast-induced acute kidney injury
CN107982231B (zh) * 2018-01-03 2021-05-07 江苏吴中医药集团有限公司 一种盐酸曲美他嗪片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3262852A (en) * 1966-07-26 Vasodilator and anti-anginose com- pounds containing methoxy benzyl piperazines and method of using the same
FR805M (cg-RX-API-DMAC7.html) * 1960-06-30 1961-09-01

Also Published As

Publication number Publication date
IT8149377A1 (it) 1983-03-28
CA1169775A (fr) 1984-06-26
FR2490963A1 (fr) 1982-04-02
BE890568A (fr) 1982-03-30
GB2084019B (en) 1984-09-12
IE812256L (en) 1982-03-30
IE51764B1 (en) 1987-03-18
IT1171557B (it) 1987-06-10
GB2084019A (en) 1982-04-07
ZA816766B (en) 1982-09-29
DE3139005A1 (de) 1982-05-06
FR2490963B1 (fr) 1986-04-18
IT8149377A0 (it) 1981-09-28
AU7574481A (en) 1982-04-08
LU83654A1 (fr) 1982-04-14
AU550761B2 (en) 1986-04-10
GR75803B (cg-RX-API-DMAC7.html) 1984-08-02
US4407801A (en) 1983-10-04
NZ198435A (en) 1984-02-03

Similar Documents

Publication Publication Date Title
DE69604762T2 (de) Verfahren und formulierungen zur modulation der sexualreaktion beim menschen
CH650675A5 (fr) Composition pharmaceutique notamment a action anti-ischemique.
Bacon et al. Blindness from quinine toxicity.
RU2720204C1 (ru) Сублингвальная фармацевтическая композиция эдаравона и (+)-2-борнеола
EP0318398B1 (fr) Forme à libération prolongée du diltiazem et son médicament ainsi obtenu
KR20250026419A (ko) 글리부리드 및 다른 약물의 정맥내 투여를 위한 방법
JPH07506356A (ja) 眼用の医薬製剤およびその製造方法
EP1212060A1 (fr) Utilisation de la nicotine ou de ses derives dans un medicament pour le traitement des maladies neurologiques, notamment la maladie de parkinson
US20200214990A1 (en) Tadalafil orally dissolving film and preparation method thereof
TW202112359A (zh) sGC活化劑於治療眼科疾病之用途
IL301971A (en) Treatment of bipolar disorders and psychosis using dexmedetomidine hydrochloride
WO2011019732A1 (en) Methods for iontophoretically treating nausea and migraine
EP2943182A1 (fr) Forme galenique pour l'administration d'un principe actif
EP0016890A1 (fr) Nouvelle forme galénique d'administration de la bêtahistine
Tamaki et al. Effects of lomerizine, a calcium channel antagonist, on retinal and optic nerve head circulation in rabbits and humans
EP0063973A1 (fr) Composition pour collyre à base de sulfate de chondroitine A
Mouly et al. Pharmacodynamics of a new ophthalmic mydriatic insert in healthy volunteers: potential alternative as drug delivery system prior to cataract surgery
EP0413694B1 (fr) Preparations medicamenteuses cardio-protectrices comprenant l'amiodarone, un derive nitre, notamment le dinitrate d'isosorbide et facultativement un beta-bloqueur
JP2004331502A (ja) 視神経細胞保護剤
DE60016038T2 (de) Neue verwendung von levosimendan
TW202444406A (zh) 一種白殭菌素用於製備抑制血管新生藥物之用途
Aditya Formulation and Evaluation of Cyclosporine Loaded Wafer for The Treatment Dry Eye Syndrome
CN112438970A (zh) 米那普仑或/和米那普仑的药用盐的新用途
IL311532A (en) Sublingual epinephrine formulations and methods of use
RU2356520C1 (ru) Способ лечения постконтузионного повреждения сетчатки глаза

Legal Events

Date Code Title Description
PL Patent ceased